Related Articles
Genetic alterations in epidermal growth factor receptor‑tyrosine kinase inhibitor‑naïve non‑small cell lung carcinoma
A peptide antigen derived from EGFR T790M is immunogenic in non‑small cell lung cancer
Continuous exposure of non‑small cell lung cancer cells with wild‑type EGFR to an inhibitor of EGFR tyrosine kinase induces chemoresistance by activating STAT3
LXR ligands induce apoptosis of EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt-NF-κB activation
Construction of a novel cell-based assay for the evaluation of anti-EGFR drug efficacy against EGFR mutation